GRIFFIN ASSET MANAGEMENT, INC.

Position in BMEA — Biomea Fusion, Inc.

CIK 883803 New York, NY

Position in BMEA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$87,906

-$1,293 QoQ

Shares Held

59,800

+2.6% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#28

of 61 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GRIFFIN ASSET MANAGEMENT, INC. holds $6,668,181 across 5 Biotechnology names. BMEA ranks #4 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,142	$3,050,915
2	SMMT	Summit Therapeutics Inc.	193,582	$2,820,489
3	ABSI	Absci Corp	56,760	$657,848
4	BMEA	Biomea Fusion, Inc. This page	59,800	$87,906
5	SANA	Sana Biotechnology, Inc.	14,620	$51,023

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$87,906	59,800	+2.6%	Shares	Sole	2026-07-23
2026-03-31	$89,199	58,300	0.0%	Shares	Sole	2026-04-30
2025-12-31	$72,292	58,300	-4.9%	Shares	Sole	2026-02-06
2025-09-30	$123,826	61,300	+19.5%	Shares	Sole	2025-10-16
2025-06-30	$92,340	51,300	0.0%	Shares	Sole	2025-07-25
2025-03-31	$109,269	51,300	-45.8%	Shares	Sole	2025-04-16
2024-12-31	$366,931	94,570	-1.6%	Shares	Sole	2025-01-22
2024-09-30	$970,307	96,070	+147.0%	Shares	Sole	2024-10-15
2024-06-30	$175,005	38,890	+2.6%	Shares	Sole	2024-07-23
2024-03-31	$566,455	37,890	+39.4%	Shares	Sole	2024-04-17
2023-12-31	$394,798	27,190	—	Shares	Sole	2024-01-19
No filing history on record for this holder in this stock.